CI 1044,
CI-1044,
N-(9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro(1,4)diazepino(6,7,1-hi)indol-3-yl)nicotinamide,
CI-1044,
UNII-O4T475XIIY,
O4T475XIIY,
197894-84-1,
DSSTox_CID_27291,
DSSTox_RID_82245,
DSSTox_GSID_47291,
CAS-NOCAS_47291,
CHEMBL342285,
SCHEMBL6441242,
DTXSID5047291,
NOCAS_47291,
Tox21_300455,
NCGC00248057-01,
NCGC00254387-01,
HY-100246,
PD-189659,
CS-0018397,
(+)-CI-1044,
3-Pyridinecarboxamide, N-((3R)-9-amino-3,4,6,7-tetrahydro-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-,
3-Pyridinecarboxamide, N-(9-amino-3,4,6,7-tetrahydro-4-oxo-1-phenylpyrrolo(3,2,1-jk)(1,4)benzodiazepin-3-yl)-, (R)-,
D0DL6J,
XGXOSJSGDNPEEF-NRFANRHFSA-N,
CI 1044,
CID9843744,
CID 9908782,
C418118,
3-Pyridinecarboxamide, N-((3R)-9-amino-3,4,6,7-tetrahydro-4-oxo-1-phenyl(1,4)diazepino(6,7,1-hi)indol-3-yl)-,
N-(9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro(1,4)diazepino(6,7,1-hi)indol-3-yl)nicotinamide,